Applied BioCode (6598) — Capital Reinvestment Ratio
Applied BioCode (6598) has a Capital Reinvestment Ratio of 1.89x as of September 2022, meaning it reinvests 2% of its operating cash flow (NT$6.35 Million) in capital expenditures (NT$12.00 Million). See 6598 equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Applied BioCode Capital Reinvestment Ratio (2022–2022)
This chart tracks Applied BioCode's Capital Reinvestment Ratio across 1 annual periods. Check 6598 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Applied BioCode (2022–2022)
Year-by-year Capital Reinvestment Ratio for Applied BioCode from 2022 to 2022. For live market cap and broader valuation context, see Applied BioCode stock valuation.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.15x | NT$145.87 Million | NT$22.14 Million | — |